Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-08-17 07:46 UTC (UTC+2h)
 

Understanding the PK of a drug [PK / PD]

posted by Helmut Homepage - Vienna, Austria, 2017-03-20 13:40  - Posting: # 17170
Views: 590

¡Hola Javier!

» I was wondering about how to calculate the steady state of a drug when you have two different values of half life

See this post (especially the last sentence) and the warfarin example (slides 21–22). ;-)
If you extrapolate from SD to MD you have to rely on assumptions (linear PK, no saturation/induction/inhibition/capacity-limited excretion).

» (If I understand correctly the steady state of a drug takes 3-5 half lives)

It depends on how one defines sufficiently ‘close’ to true steady state (at t = ∞!). For a one-compartment model, IV administration

i  % SS
1  50
2  75
3  87.5
4  93.75
5  96.875

where i = number of half lives and % SS = 100(1 – ½i ). For EV (and more important: other models) this approach is only approximate.
Coming back to your OP: I would trust the results of the MD study’s PopPK-model more than the SD study’s results derived by NCA.

[image]All the best,
Helmut Schütz 
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
17,199 Posts in 3,683 Threads, 1,054 registered users;
33 users online (1 registered, 32 guests).

To call the statistician after the experiment is done
may be no more than asking him to perform a postmortem examination:
he may be able to say what the experiment died of.    R.A. Fisher

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed